Literature DB >> 25128961

Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up.

Shinya Komori1, Kyoko Ishida, Tetsuya Yamamoto.   

Abstract

PURPOSE: To conduct a ≥15-year follow-up assessment of the visual field (VF) in normal-tension glaucoma (NTG) patients receiving medical therapy and to identify risk factors for VF progression.
DESIGN: A retrospective clinical study.
METHODS: Medical records of 78 eyes of 78 NTG patients monitored for ≥15 years were reviewed. VF progression was defined by a mean deviation (MD) deteriorated twice by 3.00 dB from baseline (MD criterion) and an annual decrease in the MD slope exceeding -0.5 dB/year (MD slope criterion). Logistic regression analysis was employed to identify risk factors for VF progression.
RESULTS: The mean follow-up period was 18.3 years. The average intraocular pressure (IOP) before treatment was 15.1 ±1.9 mmHg and the average treated IOP was 13.5 ±1.5 mmHg with 2.0 medications. Forty-two eyes (53.8%) showed VF progression using the MD criterion and 15 eyes (19.2%) showed a negative MD slope less than -0.5 dB/year. Disc hemorrhage (DH) was observed in 30 eyes (38.5%). The mean VF progression rate was -0.38 ±0.30 dB/year in the DH group and -0.24 ±0.28 dB/year in the non-DH group (P = 0.012). Multiple logistic regression analysis identified DH [relative risk (RR) 4.28; P = 0.028] as a risk factor for VF progression using the MD criterion. DH (RR 8.77; P = 0.007) and IOP fluctuation during follow-up (RR 5.03; P = 0.048) were detected as risk factors using the MD slope criterion.
CONCLUSIONS: DH and IOP fluctuation were associated with VF progression in NTG during long-term therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25128961     DOI: 10.1007/s00417-014-2767-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  37 in total

1.  Natural history of normal-tension glaucoma.

Authors:  D R Anderson; S M Drance; M Schulzer
Journal:  Ophthalmology       Date:  2001-02       Impact factor: 12.079

2.  Optic disk characteristics before the occurrence of disk hemorrhage in glaucoma patients.

Authors:  S K Law; R Choe; J Caprioli
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

Review 3.  An evidence-based review of prognostic factors for glaucomatous visual field progression.

Authors:  Paul J Ernest; Jan S Schouten; Henny J Beckers; Fred Hendrikse; Martin H Prins; Carroll A Webers
Journal:  Ophthalmology       Date:  2012-12-01       Impact factor: 12.079

4.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

5.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

6.  Risk factors for visual field progression in the low-pressure glaucoma treatment study.

Authors:  Carlos Gustavo De Moraes; Jeffrey M Liebmann; David S Greenfield; Stuart K Gardiner; Robert Ritch; Theodore Krupin
Journal:  Am J Ophthalmol       Date:  2012-07-25       Impact factor: 5.258

7.  Clinical characteristics and prognostic significance of disc hemorrhage in open-angle and angle-closure glaucoma.

Authors:  Jui-Wen Hsieh; Yu-Wen Lan; I-Jong Wang; Fang-Ju Sun
Journal:  J Glaucoma       Date:  2010-09       Impact factor: 2.503

8.  Natural history of open-angle glaucoma.

Authors:  Anders Heijl; Boel Bengtsson; Leslie Hyman; M Cristina Leske
Journal:  Ophthalmology       Date:  2009-10-24       Impact factor: 12.079

9.  Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.

Authors:  Joseph Caprioli; Anne L Coleman
Journal:  Ophthalmology       Date:  2008-02-20       Impact factor: 12.079

10.  A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients.

Authors:  G Tomita; M Araie; Y Kitazawa; S Tsukahara
Journal:  Eye (Lond)       Date:  2004-10       Impact factor: 3.775

View more
  22 in total

1.  Impact of intraocular pressure reduction on visual field progression in normal-tension glaucoma followed up over 15 years.

Authors:  Shinya Oie; Kyoko Ishida; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2017-05-26       Impact factor: 2.447

2.  Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15 mmHg.

Authors:  Kosuke Nakajima; Rei Sakata; Koji Ueda; Asahi Fujita; Takashi Fujishiro; Megumi Honjo; Shiroaki Shirato; Makoto Aihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-30       Impact factor: 3.117

3.  Macular vessel density in untreated normal tension glaucoma with a hemifield defect.

Authors:  Nozomu Uchida; Kyoko Ishida; Ayako Anraku; Asuka Takeyama; Goji Tomita
Journal:  Jpn J Ophthalmol       Date:  2019-10-17       Impact factor: 2.447

4.  The impact of disc hemorrhage studies on our understanding of glaucoma: a systematic review 50 years after the rediscovery of disc hemorrhage.

Authors:  Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2018-11-21       Impact factor: 2.447

5.  Trabeculectomy With Antimetabolite Agents for Normal Tension Glaucoma: A Systematic Review and Meta-Analysis.

Authors:  Chin Lai; Shih-Chieh Shao; Yi-Hung Chen; Yu-Kai Kuo; Chi-Chun Lai; Lan-Hsin Chuang
Journal:  Front Med (Lausanne)       Date:  2022-06-28

6.  Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma.

Authors:  Bryan Chin Hou Ang; Wenqi Chiew; Vivien Cherng Hui Yip; Chun Hau Chua; Wei Shan Han; Ivan O'Neill C Tecson; Jeanne Joyce Ogle; Boon Ang Lim; Owen Kim Hee; Elton Lik Yong Tay; Vernon Khet Yau Yong; Hon Tym Wong; Leonard Wei Leon Yip
Journal:  Eye Vis (Lond)       Date:  2022-07-05

7.  Relationship between visual field progression and baseline refraction in primary open-angle glaucoma.

Authors:  Tomoko Naito; Keiji Yoshikawa; Shiro Mizoue; Mami Nanno; Tairo Kimura; Hirotaka Suzumura; Yuzo Umeda; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2016-07-28

8.  The relationship between self-reported habitual exercise and visual field defect progression: a retrospective cohort study.

Authors:  Satoshi Yokota; Yuji Takihara; Kanako Kimura; Yoshihiro Takamura; Masaru Inatani
Journal:  BMC Ophthalmol       Date:  2016-08-23       Impact factor: 2.209

9.  Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma.

Authors:  Keiji Yoshikawa; Shiro Mizoue; Koji Nitta; Hiroshi Onishi; Masaharu Ikeda; Akemi Mizuno; Kaori Kawazoe; Yoshiyuki Tamada; Ryuji Takeda; Shun Matsumoto
Journal:  Clin Ophthalmol       Date:  2021-07-06

10.  Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma.

Authors:  Chen Qiu; Shaohong Qian; Xinghuai Sun; Chuandi Zhou; Fanrong Meng
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.